Canine

Canine Sinonasal Aspergillosis: Diagnosis and Treatment

Nov 21, 2026 5 min read
AI-generated clinical reference · Sources and methodology

Bottom line

Build the diagnosis of canine sinonasal aspergillosis from concordant clinical, imaging, endoscopic and ancillary findings rather than a fungal test in isolation. The multicenter diagnostic cohort emphasizes this combined approach and the limitations of individual test yields. [1] Plan access to affected sites, address concurrent local disease and define a reassessment endpoint before choosing treatment.

From reading to clinical reasoning

Pressure-test the decisions behind this article

Open Clinical Desk with the public topic prefilled. Add patient context only after you are inside the secure vet workspace.

canine sinonasal aspergillosis diagnosis treatment

Patient details stay inside the authenticated workspace.

Localize disease without assuming the cause of nasal blood

Record discharge character, laterality, pain, facial change, previous treatment and the course of recurrence. Document whether the concern is confined to the sinonasal region or whether other findings require a broader investigation. A photograph of epistaxis should not become a fungal diagnosis.

The canine hemostasis workup addresses systemic bleeding concerns before invasive investigation. If visual impairment accompanies the presentation, the canine acute-vision-loss pathway addresses ocular versus post-retinal localization rather than attributing the deficit to the nasal lesion by proximity alone.

Preserve the actual examination and imaging findings in the referral. State what remains uncertain and whether bleeding, respiratory compromise or another problem changes the safe order of procedures.

Combine anatomical assessment and representative testing

Prior and colleagues retrospectively described 475 UK referral cases. Diagnosis used compatible clinical and anatomical findings with observed plaques or positive ancillary testing under specified inclusion criteria. Ancillary test yields were imperfect, and the authors recommend integrating imaging, visual inspection and laboratory evidence. [1]

Those results should not be presented as a universal sensitivity estimate for every dog with nasal discharge. Test-performance calculations were based on selected dogs with observed plaques, and collection, handling and laboratory methods were not standardized. Cases lacking plaques and positive ancillary results were excluded from the main analysis. [1]

Coordinate imaging, rhinoscopy and representative sample collection with the receiving service. Label the precise site and specimen type, and retain prior antifungal exposure in the submission record. A discordant result should lead to review of what was sampled and what question remains, rather than automatic acceptance or exclusion of the working diagnosis.

Look for a second local problem

Rösch and Oechtering described primary and secondary sinonasal aspergillosis in a retrospective referral series. Some dogs had concurrent nasal or perinasal pathology, including plant foreign bodies and dental-root disease. Imaging and endoscopy were used to investigate these contributors. [2]

This supports an anatomical review beyond the fungal finding. Ask whether an underlying lesion still needs removal, dental treatment or another intervention. Record which abnormalities are confirmed and which are only suspected, and distinguish correction of a predisposing lesion from treatment of the fungal component.

The series was small and retrospective, with treatment and follow-up decisions made by specialists rather than randomized assignment. [2] It does not prove that every concurrent lesion caused the fungal disease or establish one intervention for all primary and secondary cases.

Choose treatment around access and source control

A related UK treatment cohort evaluated 436 dogs managed with several local and medical approaches. More complete debridement was associated with better treatment outcomes, but completeness was assessed subjectively from clinical records. Treatment selection could reflect disease severity, location and clinician preference. [3]

Discuss which affected sites can be accessed, the intended extent of debridement, whether a local antifungal approach is appropriate and the risks and practical requirements of repeat intervention. Verify the formulation and applicable prescribing requirements with the treating service. No single soak concentration, duration or drug regimen follows from a cohort summary.

The small oral-antifungal-monotherapy group had no recorded complete clinical remissions. [3] This argues against presenting an oral prescription as an evidence-equivalent substitute for the local approaches evaluated, while remaining distinct from a claim that systemic treatment can never have a role.

Apparent similarities between procedure groups also do not establish equivalence. These were observational comparisons with heterogeneous approaches and follow-up, not randomized choices between otherwise identical patients. [3] The diagnostic and treatment papers describe related UK populations and should not be counted as independent replication of the same finding.

Separate symptom remission from the remaining local question

The treatment study defined complete clinical remission as resolution of signs without ongoing treatment. Its first-treatment and final-treatment outcomes were separate, and some dogs underwent repeated procedures. [3]

At follow-up, document symptoms, local findings, residual uncertainty and treatment tolerance. Decide whether further examination, imaging or sampling would change care rather than equating either persistent discharge or a single negative test with the entire disease state.

A referral handoff should include original images, endoscopy observations, specimen results, interventions and the unresolved anatomical questions. Explain what would trigger earlier assessment and who will interpret the next result. A useful endpoint connects the patient's clinical recovery with the local problem still being monitored.

Frequently Asked Questions

Can an ancillary fungal test alone establish canine sinonasal aspergillosis?

No. The diagnostic cohort supports combining clinical findings, imaging, direct inspection and ancillary testing; test results should not replace anatomical assessment. [1]

Does a negative ancillary test reliably exclude disease?

No. Yield was imperfect in dogs with observed plaques, and study selection limits prevent treating the estimates as universal rule-out performance. [1]

Should a positive fungal finding stop investigation of dental or foreign-body disease?

No. The primary-versus-secondary case series identified concurrent nasal or perinasal pathology, including foreign bodies and dental-root disease. [2]

Did the treatment cohort prove rhinoscopy and trephination equivalent?

No. Treatment was not randomized, severity and operator selection could differ, and absence of a significant comparison is not equivalence. [3]

Was complete debridement associated with better treatment outcomes?

Yes, in the retrospective cohort. Assessment of completeness was subjective, so the association does not establish a guaranteed causal benefit for an individual procedure. [3]

Does the cohort support oral antifungal monotherapy as an equivalent substitute?

No. Its small oral-monotherapy group had no recorded complete clinical remissions; that observation is not proof of zero efficacy in every clinical situation. [3]

What did clinical remission mean in the treatment study?

Resolution of clinical signs without ongoing treatment. That endpoint is distinct from proving fungal eradication or normalizing every local test. [3]

References

  1. Prior et al. Diagnostic findings in sinonasal aspergillosis in dogs in the United Kingdom: 475 cases (2011–2021). Journal of Small Animal Practice. (2024)
  2. Rösch and Oechtering. Primary and Secondary Sinonasal Aspergillosis in Dogs. Animals. (2025)
  3. Prior et al. Treatment outcomes in sinonasal aspergillosis in dogs in the United Kingdom: 436 cases (2011–2021). Journal of Small Animal Practice. (2025)

More clinical updates